Gabapentin: Difference between revisions
>Dextromethorphan m Grammatics |
>Azed Made changes to: →Legal status: Unsure if including prescription drug monitoring details is relevant or not. Added Phenibut to the list of "see also" |
||
Line 109: | Line 109: | ||
*'''Switzerland:''' Gabapentin is listed as a "Abgabekategorie B" pharmaceutical, which requires a prescription.{{citation needed}} | *'''Switzerland:''' Gabapentin is listed as a "Abgabekategorie B" pharmaceutical, which requires a prescription.{{citation needed}} | ||
*'''United States:''' Gabapentin is not a scheduled substance but may only be sold with prescription.<ref>Peckham, A. M., Ananickal, M. J., & Sclar, D. A. (2018). Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance. Risk management and healthcare policy, 11, 109.https://dx.doi.org/10.2147%2FRMHP.S168504</ref> | *'''United States:''' Gabapentin is not a scheduled substance but may only be sold with prescription.<ref>Peckham, A. M., Ananickal, M. J., & Sclar, D. A. (2018). Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance. Risk management and healthcare policy, 11, 109.https://dx.doi.org/10.2147%2FRMHP.S168504</ref> | ||
**''' | **'''Exceptions:''' Gabapentin is a Schedule 5 controlled substance in: Alabama, Kentucky, Michigan, North Dakota, Tennessee, Virginia, and West Virginia. With prescription drug monitoring in: Connecticut, District of Columbia, Indiana, Kansas, Massachusetts, Minnesota, Nebraska, New Jersey, Ohio, Oregon, Utah, and Wyoming.<ref>Collins, S. (2021). More states make gabapentin a Schedule V Controlled Substance. ''Pharmacy Today'', ''27''(10), 33. https://doi.org/10.1016/j.ptdy.2021.09.016</ref> | ||
==See also== | ==See also== | ||
Line 118: | Line 118: | ||
*[[GABA]] | *[[GABA]] | ||
*[[Pregabalin]] | *[[Pregabalin]] | ||
*[[Phenibut]] | |||
==External links== | ==External links== |